Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Advancing drug delivery systems for the treatment of multiple sclerosis.
Increased S-nitrosothiols are associated with spinal cord injury in multiple sclerosis.
Brugada sign in a multiple sclerosis patient: Relation to autonomic nervous system dysfunction and therapeutic dilemmas.
Multisystem involvement in neuromyelitis optica.
CD62L is not a reliable biomarker for predicting PML risk in natalizumab-treated R-MS patients.
Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview.
Age-related changes in spleen of Dark Agouti rats immunized for experimental autoimmune encephalomyelitis.
Disability caused by multiple sclerosis is associated with the number of extra cranial venous stenoses: possible improvement by venous angioplasty. Results of a prospective study.
Biological markers in cerebrospinal fluid for axonal impairment in multiple sclerosis: acetylcholinesterase activity cannot be considered a useful biomarker.
Human adipose-derived mesenchymal stem cells engineered to secrete IL-10 inhibit APC function and limit CNS autoimmunity.
Within-lesion differences in quantitative MRI parameters predict contrast enhancement in multiple sclerosis.
Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study.
Analytical performances of SPAPLUS® turbidimeter for the quantification of albumin and IgG in serum and cerebrospinal fluid.
A review on ROCK-II inhibitors: From molecular modelling to synthesis.
Chronic pain in multiple sclerosis: Is there also fibromyalgia? An observational study.
Children and adolescents adjustment to parental multiple sclerosis: a systematic review.
Brain glycolipids suppress T helper cells and inhibit autoimmune demyelination.
The effect of glia-glia interactions on oligodendrocyte precursor cell biology during development and in demyelinating diseases.
The secretome of mesenchymal stem cells: Potential implications for neuroregeneration.
Current and new directions in MRI in multiple sclerosis.
Myelin architecture: zippering membranes tightly together.
The gateway theory: bridging neural and immune interactions in the CNS.
B7-H1 Selectively Controls TH17 Differentiation and Central Nervous System Autoimmunity via a Novel Non-PD-1-Mediated Pathway.
Neuroinflammation and Depression: Microglia Activation, Extracellular Microvesicles and microRNA Dysregulation.
Activation of microglial P2Y12 receptor is required for outward potassium currents in response to neuronal injury.
Pages
« first
‹ previous
…
468
469
470
471
472
473
474
475
476
…
next ›
last »